Concerns about liver toxicity are fueling changes for pemoline and Cymbalta

December 2005

Concerns about liver toxicity are fueling changes for pemoline and Cymbalta.

Pemoline will go off the market...due to liver failure.

You can continue to dispense pemoline until it runs out... but suggest switching these patients to a different ADHD med.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Electronic prescribing will usher in a new era of "second generation" med errors
Women's Health whether they should stop using the Ortho Evra contraceptive patch
Women's Health new human papillomavirus (HPV) vaccines
Neurology & Pain avoid alcohol while taking Avinza or Kadian (long-acting morphine)
Infectious Diseases FDA says antibacterial soaps and washes aren't any better than plain soap and water for home use
Infectious Diseases Can patients with a penicillin allergy take cephalosporins or other beta-lactam antibiotics
Dyslipidemia whether patients can use other niacin products in place of Niaspan
Diabetes DISPOSABLE blood glucose meter called Sidekick
Cardiology more drug interaction alerts for amiodarone
Concerns about liver toxicity are fueling changes for pemoline and Cymbalta
Combining a triptan and an NSAID is more effective than either drug alone for treating migraines
Supplements Cold-fX prevents the common cold
Supplements Brazilian Diet Pills
people to learn more about their family health history
Practice glucosamine, chondroitin, and selenium for osteoarthritis